🎯 How can we make #PrecisionMedicine real for #glioblastoma? 🧠 The #ATTRACT trial tests 28 drugs on patient-derived cells & uses a molecular tumor board for #personalized therapy recommendation. 📚 Read our protocol paper in #NeuroOncology Advances: doi.org/10.1093/noaj... 📲 Follow us for updates!

🚀 #ATTRACT wächst! ⛔️ #KlinischeStudien sollten nicht nur auf wenige Zentren beschränkt sein. Deshalb erweitern wir unser #Biobanking, um Patient:innen mit #Glioblastom in ganz #Österreich 🇦🇹 Zugang zu ATTRACT zu ermöglichen. 🎉 Meilenstein: 1. Patient in Wiener Neustadt eingeschlossen!

🚀 #ATTRACT is growing! ⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT. 🎉 Milestone: 1st patient enrolled in Wiener Neustadt! #NeuroOncology #PrecisionMedicine #CancerResearch

🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy. Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀 youtu.be/NfxxMZ_xmF4

🚀 We’re launching the BlueSky presence of #ATTRACT - a 🇦🇹 Clinical Research Group investigating ex-vivo drug screening 💊 for personalized #glioblastoma treatment, funded by @lbg.ac.at with @meduniwien.ac.at as lead institution. ➡️ Follow us for further insights! 🧠 #GlioblastomaAwarenessDay #NeuroOnc